ITCR Funding Opportunities
There are currently no active funding opportunities for the ITCR program, but a series of Forecasts have been published to announce the intent to issue new RFAs:
- FOR-CA-25-073: Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01)
- FOR-CA-25-074: Advanced Development of Informatics Technologies for Cancer Research and Management (U24)
- FOR-CA-25-075: Sustained Support for Informatics Technologies for Cancer Research and Management (U24)
Forecasted dates are estimates and application receipt dates may shift based on the actual publication date; funding opportunities are generally available for at least 60 days before the first due date. Below you can find past funding opportunities to get familiar with the scope and requirements of prior versions of these RFAs.
Algorithm Development
RFA-CA-24-016: Development of Innovative Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)
This NOFO supports the development of innovative methods and algorithms in biomedical computing, informatics, and data sciences addressing priority needs across the cancer research continuum.
Budget: Up to $275,000 Direct Costs over a two-year period, with no more than $200,000 requested in a single year.
Early-Stage Tool Development
RFA-CA-24-017: Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
This NOFO supports the early-stage development of informatics technology to improve the acquisition, management, and/or analysis of data addressing priority needs across the cancer research continuum. Early-stage development is defined as initial tool development or the significant modification of an existing tool for a new application.
Budget: Up to $300,000 Direct Costs per year for up to three years.
Enhancement & Dissemination
RFA-CA-24-018: Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
This NOFO supports the advanced development and enhancement of emerging informatics technologies to improve the acquisition, management, and/or analysis of data addressing priority needs across the cancer research continuum.
Budget: Up to $600,000 Direct Costs per year for up to five years.
Sustainment
RFA-CA-24-019: Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
This NOFO supports sustaining operations and improving the user experience and availability of existing, widely-adopted informatics tools and resources addressing needs across the cancer research continuum.
Budget: Application budgets are not limited but must reflect the actual needs of the proposed project.
Related Funding Opportunities
Innovative Molecular Analysis Technologies (IMAT): Researchers focusing development of novel, physical laboratory technologies should consider one of the IMAT Funding Opportunities.
Bioengineering Research Grants: Interdisciplinary research teams proposing to develop new tools, methods, and techniques and apply them to a specific problem in basic or clinical cancer research should consider the bioengineering research grant R01 opportunities (PAR-22-242 or PAR-22-243) or the exploratory/developmental bioengineering research grant R21 opportunities (PAR-22-090 or PAR-22-091). Research teams composed of academic and industrial partners proposing to accelerate the development and adoption of promising bioengineering tools should consider PAR-22-123.
Academic Industrial Partnerships for Translation of Technologies: Interdisciplinary research teams composed of academic and industrial partners proposing to develop and translate a technological solution to a problem in basic or clinical research should consider PAR-21-166 or PAR-21-206. Teams specifically focused on translating engineering developments in imaging, data science, and/or spectroscopic technologies should consider PAR-23-259.
Translation and Transfer of Informatics Technologies: NCI’s small business innovative research (SBIR) development center has funding opportunities and resources for small businesses and researchers collaborating with small businesses to develop informatics technology for cancer research.
Artificial Intelligence in Cancer Research: NCI funds and supports research to advance the use of AI in cancer research. Find out more about funding opportunities and other ways to engage in advancing AI for cancer research.